Amber Therapeutics

Doing the extraordinary to restore the ordinary

London, United Kingdom · Founded 2021 · $100.0M raised

Headquarters
London
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Series AJun 2024
Rounds
2

About

Amber Therapeutics was founded in 2021 by Aidan Crawley, Tim Denison, Stefan De Wachter, and Charles Knowles with a mission to develop breakthrough neuromodulation therapies for areas of unmet clinical need. Its lead program, Amber-UI, is the world's first fully implantable, closed-loop adaptive neuromodulation therapy targeting the pudendal nerve to treat mixed urinary incontinence — a condition affecting 40 million women in the US. The company completed successful first-in-human implants in the AURA-2 feasibility study and is advancing toward US FDA approval.

Summary

Amber Therapeutics is a Healthcare company based in London, United Kingdom, founded in 2021. It has raised $100.0M in total across 2 rounds, most recently a $100.0M Series A round in Jun 2024. Investors include New Enterprise Associates, Oxford Science Enterprises and F-Prime Capital.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2024
$100.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amber Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/amber-therapeutics"><img src="https://indexed.vc/api/badge/company/amber-therapeutics" alt="Amber Therapeutics on Indexed.vc" width="260" height="76" /></a>